U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07461935) titled 'ALPs Single ChambEr New Device' on March 02.
Brief Summary: Prospective, non-randomized, multi-center, international study designed to evaluate the initial safety and performance of the ALPS leadless pacemaker when used in patients with bradycardia.
Study Start Date: June, 2026
Study Type: INTERVENTIONAL
Condition:
Bradycardia
Brady-tachy Syndrome
AV Block
Atrial Fibrillation (AF)
Intervention:
DEVICE: Leadless ventricular pacemaker implantation
Participants will undergo leadless ventricular pacemaker implantation providing pacing therapy by the implant and monitoring using the home monitor.
Recruitment Status: NOT_YET_RECR...